Evidence map›Paper›PMID 37307967›Full record

ArticleInternational journal of biological macromolecules2023

Definition of fatty acid transport protein-2 (FATP2) structure facilitates identification of small molecule inhibitors for the treatment of diabetic complications.

Mukesh Kumar, Robert J Gaivin, Shenaz Khan, Yuriy Fedorov, Drew J Adams, Weiyang Zhao, Hsueh-Yun Lee, Xinghong Dai, Chris G Dealwis, Jeffrey R Schelling

Open access · greenAbstract read
In one paragraph

Article in International journal of biological macromolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Mukesh KumarDepartment of Pharmacology, Case Western Reserve University, Cleveland, OH 44106, United States of America.
Robert J GaivinDepartment of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH 44106, United States of America.
Shenaz KhanDepartment of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH 44106, United States of America.
Yuriy FedorovDepartment of Genetics, Case Western Reserve University, Cleveland, OH 44106, United States of America.
Drew J AdamsDepartment of Genetics, Case Western Reserve University, Cleveland, OH 44106, United States of America.
Weiyang ZhaoDepartment of Biochemistry, Case Western Reserve University, Cleveland, OH 44106, United States of America.
Hsueh-Yun LeeSchool of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan.
Xinghong DaiDepartment of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH 44106, United States of America.
Chris G DealwisDepartment of Pharmacology, Case Western Reserve University, Cleveland, OH 44106, United States of America; Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106, United States of America.
Jeffrey R SchellingDepartment of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH 44106, United States of America; Department of Medicine, Case Western Reserve University, Cleveland, OH 44106, United States of America. Electronic address: jrs15@case.edu.
Case Western Reserve University · USTaipei Medical University · TW

Funding

Mechanisms of tubular atrophy in renal diseaseR01DK067528 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI SCHELLING, JEFFREY R · 2005 to 2025
$7.1M
NIDDK NIH HHS R01 DK067528
6 · The paper itself

Abstract

Diabetes is a major public health problem due to morbidity and mortality associated with end organ complications. Uptake of fatty acids by Fatty Acid Transport Protein-2 (FATP2) contributes to hyperglycemia, diabetic kidney and liver disease pathogenesis. Because FATP2 structure is unknown, a homology model was constructed, validated by AlphaFold2 prediction and site-directed mutagenesis, and then used to conduct a virtual drug discovery screen. In silico similarity searches to two low-micromolar IC

Indexed as

Diabetes ComplicationsDiabetes MellitusBiological TransportDrug DiscoveryFatty AcidsFatty Acid Transport ProteinsHumansMolecular Docking SimulationMolecular Dynamics SimulationFatty AcidsFatty Acid Transport ProteinsDrug discoveryFATP2Molecular dynamics simulation

Identifiers

PMID37307967
PMCPMC10527240
OpenAlexW4380152099

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.